TLR8 and COVID-19: Treatment of these whole blood samples with the small molecule R848, a mimic of TLR7 and TLR8 activation by single strand RNA, increased the percentage of IL-6+ blood monocytes, with significantly higher levels in samples from COVID-19 patients compared to healthy controls (Fig. 5B).